FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Urges Reporting of Home Covid Test Results

FDA revises its online guide on when and how often people should use an over-the-counter at-home Covid-19 test to encourage users to self-report their...

latest-news-card-1
Biologics

Takeda sBLA for Takhzyro Expanded Indication

FDA approves a Takeda supplemental BLA for an expanded use of Takhzyro (lanadelumab-flyo) prophylaxis to prevent attacks of hereditary angioedema in ...

latest-news-card-1
Federal Register

Determinations on 31 Drugs Available for ANDAs

Federal Register notice: FDA determines that 31 drug products were not withdrawn from sale due to safety or effectiveness reasons.

latest-news-card-1
Human Drugs

Rapid-Acting Depression Drug Gets Priority Review

FDA accepts for priority review a Biogen and Sage Therapeutics, NDA for zuranolone, a rapid-acting once daily oral drug for major depressive disorder ...

latest-news-card-1
Medical Devices

Group Seeks Clinical Decision Support Guide Rescission

A citizen petition from the Clinical Decision Support (CDS) Coalition urges FDA to rescind its controversial 9/2022 final guidance on Clinical Decisio...

latest-news-card-1
Human Drugs

MD Sentenced in Avanir Kickbacks

Former physician Deepak Raheja (Hudson, Ohio) gets 30 months in prison after pleading guilty to pharmaceutical kickback conspiracy charges involving t...

latest-news-card-1
Medical Devices

Abbott Expanded Indication for Ablation Catheter

FDA approves an Abbott expanded indication for its FlexAbility Ablation Catheter, Sensor Enabled, a flexible tip catheter intended to help physicians ...

Human Drugs

Tezspire Approved as Pre-filled Pen for Asthma

FDA approves AstraZeneca and Amgens asthma drug Tezspire (tezepelumab) in a self-administration pre-filled, single-use pen for patients aged 12 years ...

latest-news-card-1
Federal Register

Meeting on Developing Digital Health Technologies

Federal Register notice: FDA announces a 3/28-29 public workshop entitled Understanding Priorities for the Development of Digital Health Technologies ...

latest-news-card-1
Federal Register

Workshop on Generic Drug Science Initiatives

Federal Register notice: FDA announces a 5/11 public workshop entitled FY 2023 Generic Drug Science and Research Initiatives Workshop.